Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy

por Bengtson, Lindsay G.S., DePietro, Michael, McPheeters, Jeffrey, Fox, Kathleen M.
Publicado 2018

COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA

por Hanania, Nicola A, Bunner, Scott H, Bengtson, Lindsay G S, Ismaila, Afisi S, Bogart, Michael
Publicado 2023

Development and validation of a drug adherence index for COPD

por Bengtson, Lindsay G S, Bancroft, Tim, Schilling, Craig, Buikema, Ami R, Stanford, Richard H
Publicado 2021

Comparison of COPD health care utilization and associated costs across patients treated with LAMA+LABA fixed-dose therapies

por Palli, Swetha R, Xie, Bin, Chastek, Benjamin, Elliott, Caitlin A, Bengtson, Lindsay G S
Publicado 2021

Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy...

por Singer, David, Bengtson, Lindsay G S, Elliott, Caitlin, Buikema, Ami R, Franchino-Elder, Jessica
Publicado 2020

Burden of illness in progressive fibrosing interstitial lung disease

por Singer, David, Bengtson, Lindsay G S, Conoscenti, Craig S, Anderson, Amy J, Brekke, Lee, Shetty, Sharash S, Brown, Kevin K
Publicado 2022

Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States

por Singer, David, Bengtson, Lindsay G. S., Conoscenti, Craig S., Laouri, Marianne, Shetty, Sharash S., Anderson, Amy J., Brown, Kevin K.
Publicado 2022

Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilante...

por Sethi, Sanjay, Clark, Brendan, Bengtson, Lindsay G S, Buysman, Erin K, Palli, Swetha, Sargent, Andrew, Shaikh, Asif, Ferguson, Gary T
Publicado 2023

Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umecl...

por Sethi, Sanjay, Palli, Swetha R, Bengtson, Lindsay G S, Buysman, Erin K, Clark, Brendan, Sargent, Andrew, Shaikh, Asif, Ferguson, Gary T
Publicado 2023

Meningococcal Vaccination Rates Among People With a New Diagnosis of HIV Infection in the US

por Ghaswalla, Parinaz K., Marshall, Gary S., Bengtson, Lindsay G. S., Buikema, Ami R., Bancroft, Tim, Koep, Eleena, Novy, Patricia, Hogea, Cosmina S.
Publicado 2022

Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United States

por Marshall, Gary S, Ghaswalla, Parinaz K, Bengtson, Lindsay G S, Buikema, Ami R, Bancroft, Tim, Koep, Eleena, Novy, Patricia, Hogea, Cosmina S
Publicado 2021

Frequency of Care and Mortality Following an Incident Diagnosis of Peripheral Artery Disease in the Inpatient or Outpatient Setting: The ARIC (Atherosclerosis Risk in Communities)...

por Kalbaugh, Corey A., Loehr, Laura, Wruck, Lisa, Lund, Jennifer L., Matsushita, Kunihiro, Bengtson, Lindsay G. S., Heiss, Gerardo, Kucharska‐Newton, Anna
Publicado 2018

Peripheral Artery Disease Prevalence and Incidence Estimated From Both Outpatient and Inpatient Settings Among Medicare Fee‐for‐Service Beneficiaries in the Atherosclerosis Risk in...

por Kalbaugh, Corey A., Kucharska‐Newton, Anna, Wruck, Lisa, Lund, Jennifer L., Selvin, Elizabeth, Matsushita, Kunihiro, Bengtson, Lindsay G. S., Heiss, Gerardo, Loehr, Laura
Publicado 2017

Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation

por Norby, Faye L., Bengtson, Lindsay G.S., Lutsey, Pamela L., Chen, Lin Y., MacLehose, Richard F., Chamberlain, Alanna M., Rapson, Ian, Alonso, Alvaro
Publicado 2017

A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants

por Claxton, J’Neka S., MacLehose, Richard F., Lutsey, Pamela L., Norby, Faye L., Chen, Lin Y., O’Neal, Wesley T., Chamberlain, Alanna M., Bengtson, Lindsay G. S., Alonso, Alvaro
Publicado 2018

Impact of Atrial Fibrillation on Healthcare Utilization in the Community: The Atherosclerosis Risk in Communities Study

por Bengtson, Lindsay G. S., Lutsey, Pamela L., Loehr, Laura R., Kucharska‐Newton, Anna, Chen, Lin Y., Chamberlain, Alanna M., Wruck, Lisa M., Duval, Sue, Stearns, Sally C., Alonso, Alvaro
Publicado 2014

Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation

por Chen, Nemin, Lutsey, Pamela L., MacLehose, Richard F., Claxton, J'Neka S., Norby, Faye L., Chamberlain, Alanna M., Bengtson, Lindsay G. S., O'Neal, Wesley T., Chen, Lin Y., Alonso, Alvaro
Publicado 2018

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation

por O'Neal, Wesley T., Sandesara, Pratik B., Claxton, J'Neka S., MacLehose, Richard F., Chen, Lin Y., Bengtson, Lindsay G. S., Chamberlain, Alanna M., Norby, Faye L., Lutsey, Pamela L., Alonso, Alvaro
Publicado 2018

Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation

por O’Neal, Wesley T., Alam, Aniqa B., Sandesara, Pratik B., Claxton, J’Neka S., MacLehose, Richard F., Chen, Lin Y., Bengtson, Lindsay G. S., Chamberlain, Alanna M., Norby, Faye L., Lutsey, Pamela L., Alonso, Alvaro
Publicado 2019

Comparable Ascertainment of Newly-Diagnosed Atrial Fibrillation Using Active Cohort Follow-Up versus Surveillance of Centers for Medicare and Medicaid Services in the Atheroscleros...

por Bengtson, Lindsay G. S., Kucharska-Newton, Anna, Wruck, Lisa M., Loehr, Laura R., Folsom, Aaron R., Chen, Lin Y., Rosamond, Wayne D., Duval, Sue, Lutsey, Pamela L., Stearns, Sally C., Sueta, Carla, Yeh, Hsin-Chieh, Fox, Ervin, Alonso, Alvaro
Publicado 2014